NCT03444350

Brief Summary

The purpose of this study is to evaluate the clinicaland laboratory (as oxidative stress and pro-inflammatory mediators) effects of the use of gaseous ozone in periodontal treatment in addition to scaling and root planning. The study population consisted of 40 patients with CP (chronic periodontitis). It was performed with two groups; The Test Group, and the Control Group. SRP plus gaseous ozone \[1 W (100 mJ, 10 Hz)\] was applied to the Test Group. The Control Group, on the other hand, had only SRP.The clinical periodontal parameters were performed and saliva samples were taken before SRP (baseline) and 1 month after treatment. The periodontal examination involved assessing the plaque index, gingival index , probing depth, and clinical attachment level. The total antioxidant status, total oxidant status, nitric oxide, 8-hidroxi-deoksiguanosine, myeloperoxidase, glutathione, malondialdehyde and transforming growth factor-beta levels were determined in the saliva samples.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2012

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 23, 2015

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 11, 2016

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

February 14, 2018

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 23, 2018

Completed
Last Updated

February 23, 2018

Status Verified

February 1, 2018

Enrollment Period

3.1 years

First QC Date

February 14, 2018

Last Update Submit

February 22, 2018

Conditions

Keywords

Periodontal treatmentOzoneoxidative stress

Outcome Measures

Primary Outcomes (1)

  • Laboratory findings

    The total antioxidant status levels ( mmol/L) were determined in the saliva samples.

    One month

Secondary Outcomes (1)

  • Clinical findings

    One month

Study Arms (2)

Control group

ACTIVE COMPARATOR

SRP plus placebo

Device: SRP plus placebo

Gaseous ozone group

EXPERIMENTAL

SRP plus gaseous ozone \[1 W (100 mJ, 10 Hz)\]

Device: Gaseous ozone

Interventions

SRP plus gaseous ozone

Also known as: Ozone DTA
Gaseous ozone group

only SRP

Control group

Eligibility Criteria

Age30 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients having had generalize CP which were agreed upon by consensus at the World Workshop in Periodontics in 1999 \[24\];
  • three or more teeth having at least two quadrants with probing depth between 4 and 6 mm and radiographic signs of bone loss;
  • aged 30 years and above;
  • a minimum of 20 teeth.

You may not qualify if:

  • received periodontal therapy within the last 12 months;
  • systemic diseases which could affect periodontal treatment outcomes;
  • having taken systemic antibiotics within the last 6 months;
  • pregnancy or breast-feeding for female patients.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Inonu University

Malatya, 44000, Turkey (Türkiye)

Location

Related Publications (1)

  • Seydanur Dengizek E, Serkan D, Abubekir E, Aysun Bay K, Onder O, Arife C. Evaluating clinical and laboratory effects of ozone in non-surgical periodontal treatment: a randomized controlled trial. J Appl Oral Sci. 2019 Jan 14;27:e20180108. doi: 10.1590/1678-7757-2018-0108.

MeSH Terms

Conditions

Chronic Periodontitis

Condition Hierarchy (Ancestors)

PeriodontitisPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Abubekir Eltas, Ass. Prof.

    Inonu University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
The clinician who performed the therapy (S.D.) was not informed about the modality of the treatment till the first session of each patient (right at this moment, a sealed envelope was opened and the clinician was then able to see the treatment modality). The results of the study were evaluated in a blinded manner (both before treatment and after treatment). The ozone was applied in the gingival sulcus of all teeth with a fine-tipped tool placed in the periodontal pocket. It was moved in the apical-coronal direction in a sweeping motion. Within 30 seconds, this application was applied in mesial, distal, buccal, and lingual manner. No ozone application was used in the Control Group, and they received only placebo.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: RANDOMIZED CONTROLLED TRIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

February 14, 2018

First Posted

February 23, 2018

Study Start

May 1, 2012

Primary Completion

May 23, 2015

Study Completion

August 11, 2016

Last Updated

February 23, 2018

Record last verified: 2018-02

Data Sharing

IPD Sharing
Will not share

The study has been designed in a randomized parallelly-controlled and double-blinded design as a full-mouth clinical trial. The duration of the study was 1 month. Inonu University Ethics Committee approved the study protocol in accordance with the Helsinki Declaration. Informed Consent Form were received from the participants with their signatures. The participating patients were selected from Inonu University, Department of Periodontology Patient Pool. 40 patients constituted the Study Group.

Locations